•
Jun 30, 2014

Viridian Therapeutics Q2 2014 Earnings Report

Total Revenue
$1.27M
Previous year: $1.1M
+15.5%
EPS
-$12.1
Previous year: -$2.87
+323.3%
Gross Profit
$598K
Previous year: $500K
+19.6%

Viridian Therapeutics

Viridian Therapeutics